Kook-Hwan Oh Selected Research

Angiotensinogen

1/2021	Effect of urinary angiotensinogen and high-salt diet on blood pressure in patients with chronic kidney disease: results from the Korean Cohort Study for Outcome in Patients with Chronic Kidney Disease (KNOW-CKD).
6/2015	Increased urinary Angiotensinogen/Creatinine (AGT/Cr) ratio may be associated with reduced renal function in autosomal dominant polycystic kidney disease patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kook-Hwan Oh Research Topics

Disease

47	Chronic Renal Insufficiency 06/2022 - 06/2010
18	Chronic Kidney Failure (Chronic Renal Failure) 01/2022 - 01/2009
12	Hypertension (High Blood Pressure) 04/2022 - 06/2014
12	Acute Kidney Injury (Acute Renal Failure) 11/2021 - 01/2013
9	Autosomal Dominant Polycystic Kidney (ADPKD) 07/2022 - 02/2009
8	Infections 11/2019 - 09/2008
7	Cardiovascular Diseases (Cardiovascular Disease) 04/2022 - 12/2011
7	Inflammation (Inflammations) 01/2021 - 07/2008
5	Kidney Diseases (Kidney Disease) 01/2021 - 03/2015
5	Peritoneal Fibrosis 12/2019 - 02/2010
5	Neoplasms (Cancer) 01/2019 - 09/2009
4	Fibrosis (Cirrhosis) 01/2022 - 02/2005
4	Proteinuria 12/2021 - 01/2009
4	Anemia 01/2021 - 11/2010
4	Diabetes Mellitus 11/2019 - 01/2009
4	Cysts 07/2019 - 02/2009
3	Stroke (Strokes) 06/2022 - 10/2021
3	Myocardial Infarction 06/2022 - 10/2021
3	Heart Failure 01/2022 - 12/2019
3	Type 2 Diabetes Mellitus (MODY) 01/2022 - 10/2010
3	Unstable Angina 01/2022 - 12/2019
3	Acidosis 01/2021 - 01/2012
3	Body Weight (Weight, Body) 01/2021 - 06/2011
3	Obesity 01/2021 - 01/2018
3	Chronic Kidney Disease-Mineral and Bone Disorder (Renal Rickets) 11/2019 - 09/2017
3	IGA Glomerulonephritis (IGA Nephropathy) 07/2011 - 12/2005
2	Hypotension (Low Blood Pressure) 05/2022 - 01/2021
2	Cardiac Arrhythmias (Arrythmia) 05/2022 - 10/2021
2	Dyslipidemias (Dyslipidemia) 04/2022 - 08/2014
2	Renal Insufficiency (Renal Failure) 01/2022 - 01/2021
2	Death (Near-Death Experience) 01/2022 - 10/2021
2	Coronary Artery Disease (Coronary Atherosclerosis) 12/2021 - 12/2019
2	Renal Cell Carcinoma (Grawitz Tumor) 01/2021 - 01/2014
2	Hemorrhage 01/2021 - 05/2014
2	Cerebrovascular Disorders (Cerebrovascular Occlusion) 01/2021 - 12/2019
2	Hypersensitivity (Allergy) 02/2018 - 10/2015
2	Albuminuria 01/2018 - 03/2012
2	Malnutrition (Nutritional Deficiencies) 01/2017 - 05/2003
2	Peritonitis 01/2017 - 07/2015
2	Secondary Hyperparathyroidism 01/2016 - 03/2015
2	Weight Gain 01/2013 - 01/2009
2	Lipoid Nephrosis (Glomerulonephritis, Minimal Change) 06/2012 - 01/2009
2	Vascular Calcification 09/2011 - 01/2010
1	Disease Progression 07/2022
1	Vasculitis (Vasculitides) 01/2022

Drug/Important Bio-Agent (IBA)

15	CreatinineIBA 01/2022 - 01/2011
9	MineralsIBA 06/2020 - 03/2015
8	Proteins (Proteins, Gene)FDA Link 01/2022 - 07/2011
7	Biomarkers (Surrogate Marker)IBA 07/2022 - 08/2012
5	CalciumIBA 06/2022 - 01/2015
5	omega-Chloroacetophenone (Mace)IBA 06/2022 - 12/2019
5	AdiponectinIBA 01/2021 - 01/2017
5	Dialysis SolutionsIBA 10/2019 - 05/2010
5	Glucose (Dextrose)FDA LinkGeneric 10/2019 - 10/2010
4	Hemoglobins (Hemoglobin)IBA 01/2021 - 01/2017
4	Antihypertensive Agents (Antihypertensives)IBA 01/2021 - 11/2018
4	C-Reactive ProteinIBA 01/2021 - 07/2008
4	SodiumIBA 11/2018 - 01/2013
4	Interleukin-6 (Interleukin 6)IBA 01/2012 - 07/2008
3	PotassiumIBA 12/2021 - 11/2018
3	Bicarbonates (Hydrogen Carbonate)IBA 12/2021 - 11/2019
3	Pharmaceutical PreparationsIBA 04/2021 - 08/2014
3	SaltsIBA 01/2021 - 01/2018
3	Phosphates (Orthophosphate)IBA 01/2020 - 03/2015
3	Serum AlbuminIBA 01/2019 - 07/2008
3	Phosphorus (Red Phosphorus)IBA 09/2018 - 03/2015
3	SteroidsIBA 07/2015 - 01/2009
2	OsteoprotegerinIBA 12/2021 - 01/2016
2	Contrast MediaIBA 11/2021 - 10/2021
2	Cystatin CIBA 10/2021 - 01/2020
2	LipidsIBA 02/2021 - 01/2018
2	HDL CholesterolIBA 01/2021 - 01/2019
2	AngiotensinogenIBA 01/2021 - 06/2015
2	Urea (Carbamide)FDA LinkGeneric 01/2021 - 01/2017
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2021 - 03/2012
2	NitrogenIBA 01/2021 - 01/2017
2	Dietary SodiumIBA 01/2021 - 01/2018
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 03/2020 - 12/2011
2	Fibroblast Growth Factor-23IBA 01/2020 - 01/2019
2	AlbuminsIBA 01/2020 - 01/2015
2	SolutionsIBA 01/2019 - 01/2012
2	HL156AIBA 01/2018 - 03/2016
2	ReninIBA 06/2015 - 06/2014
2	Heavy MetalsIBA 04/2015 - 03/2015
2	HematinicsIBA 01/2015 - 11/2010
2	Transforming Growth Factor beta1 (TGF beta 1)IBA 02/2010 - 02/2005
1	oxidized low density lipoproteinIBA 01/2022
1	AutoantibodiesIBA 01/2022
1	LDL CholesterolIBA 01/2022
1	Interleukin-9 (Interleukin 9)IBA 01/2022

Therapy/Procedure

15	Peritoneal Dialysis 09/2021 - 02/2005
12	Therapeutics 01/2022 - 05/2003
11	Renal Dialysis (Hemodialysis) 05/2022 - 05/2003
3	Kidney Transplantation 04/2022 - 01/2009
3	Continuous Renal Replacement Therapy 01/2021 - 01/2020
3	Continuous Ambulatory Peritoneal Dialysis (CAPD) 01/2012 - 07/2003
2	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 10/2021 - 05/2019
2	Renal Replacement Therapy (Therapies, Renal Replacement) 09/2021 - 07/2012
2	Contraindications 01/2020 - 01/2019
2	Catheters 11/2019 - 05/2014